LE Visser
Impact in
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
-
- Diabetes Treatment and Management
- Hormonal Regulation and Hypertension
Papers in
-
- Pharmacogenetics and Drug Metabolism 2
-
- Diabetes Management and Research 1
- Co-authors
- RHN van Schaik (3 shared papers)Albert Hofman (4 shared papers)Matthijs L. Becker (1 shared paper)Teun van Gelder (1 shared paper)J. C. M. Witteman (1 shared paper)Arnold G. Vulto (1 shared paper)R. Cano (1 shared paper)André G. Uitterlinden (3 shared papers)
- Journals
- Clinical Pharmacology & Therapeutics (3 papers)Acta Paediatrica (1 paper)Arteriosclerosis Thrombosis and Vascular Biology (1 paper)PubMed (1 paper)
- Partner nations
- NetherlandsSpain
In The Last Decade
LE Visser
6 papers receiving 296 citations
Peers
Comparison fields: 5 of 55
- Pharmacology 117
- Endocrinology, Diabetes and Metabolism 73
- Hepatology 22
- Cardiology and Cardiovascular Medicine 59
- Biochemistry 20
Countries citing papers authored by LE Visser
This map shows the geographic impact of LE Visser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by LE Visser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites LE Visser more than expected).
Fields of papers citing papers by LE Visser
This network shows the impact of papers produced by LE Visser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by LE Visser. The network helps show where LE Visser may publish in the future.
Co-authors
The 19 scholars most cited alongside LE Visser, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 114 | |
| 2 | 2007 | 83 | |
| 3 | 1999 | 47 | |
| 4 | 2008 | 33 | |
| 5 | 2009 | 28 | |
| 6 | No modification of the beneficial effect of NSAIDs on colorectal cancer by CYP2C9 genotype. | 2009 | 4 |
About LE Visser
LE Visser is a scholar working on Pharmacology, Endocrinology, Diabetes and Metabolism, Infectious Diseases, Surgery and Pathology and Forensic Medicine, having authored 6 papers that have together received 309 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (2 papers), Heart rate and cardiovascular health (1 paper), Diabetes Management and Research (1 paper), Alcohol Consumption and Health Effects (1 paper), Eicosanoids and Hypertension Pharmacology (1 paper), Viral gastroenteritis research and epidemiology (1 paper), Hepatitis Viruses Studies and Epidemiology (1 paper) and Salmonella and Campylobacter epidemiology (1 paper). The work is most often cited by research in Pharmacology (117 citations), Endocrinology, Diabetes and Metabolism (73 citations), Hepatology (22 citations), Cardiology and Cardiovascular Medicine (59 citations) and Biochemistry (20 citations). LE Visser has collaborated with scholars based in Netherlands and Spain. Frequent co-authors include RHN van Schaik, Albert Hofman, Matthijs L. Becker, Teun van Gelder, J. C. M. Witteman, Arnold G. Vulto, R. Cano, André G. Uitterlinden, Martina Teichert and Ron H. N. van Schaik. Their work appears in journals such as Clinical Pharmacology & Therapeutics, Acta Paediatrica, Arteriosclerosis Thrombosis and Vascular Biology and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.